The Biopharmaceutical industry is more than 40 years old. Increasing requirements from regulatory authorities and demand for biopharmaceuticals have led to ever-growing layers of complexity around equipment and facilities that are essentially based on traditional chemical engineering and stainless steel technology. As such, compliance comes at a steadily increasing capital and operational cost. Together with overall declining R&D productivity and intensifying pressure on pricing, this leads to a non-sustainable downward spiral for the pharmaceutical industry. In this session, we will discuss

• New approaches towards how biopharmaceutical processes are developed and why they are crucial for manufacturing
• Major advances achieved in the last decade with regard to process design, productivity and the development of new technologies based on single-use technologies
• Best approaches to rethink facility layout and bio manufacturing in general to tackle the social, demographic and environmental challenges ahead while remaining economically sustainable.